All In MedTech

Device Trial Radar · NCT00736424

Brain Stimulation for Epilepsy Long Term Follow-up

Last checked: Nov 20, 2026Latest source record: Jan 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

9

Actual

Start

Jun 2008

Primary completion

Nov 2010

Study completion Nov 2010

Sponsor

Lead sponsor
MedtronicNeuroNot on our public-company list
Sponsor type
Industry
First posted
Aug 15, 2008

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect subject data to evaluate the rate of sudden unexplained death in epilepsy (SUDEP) with bilateral neurostimulation of the anterior nucleus of the thalamus in people diagnosed with refractory epilepsy. The data obtained from the physician initiated studies will be pooled with data collected in Medtronic-sponsored studies to assess SUDEP risk.

Conditions

  • Epilepsy

Interventions

  • Itrel II™ and Soletra™ Epilepsy Control SystemDevice

    Bilateral neurostimulation of the anterior nucleus of the thalamus

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary objective is to collect patient data that may be pooled with other data to estimate the SUDEP rate in people with refractory epilepsy receiving bilateral deep brain stimulation of the anterior nucleus of the thalamus.Time frame: 5 years (anticipated)

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.